Universitätsklinikum Schleswig-Holstein
Universitätsklinikum Schleswig-Holstein
Kiel, Germany9 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Neoadjuvant Endocrine Therapy +/- the PI3K Inhibitor Inavolisib in HER2+, HR+, PIK3CA Mutant Early Breast Cancer | HER2-positive Breast Cancer | Recruiting | Phase 2 | 2026-09-11 | NCT05306041 | |
| Prospective Evaluation of Ivosidenib Maintenance Following Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia or High-risk Myelodysplastic Neoplasia With IDH1 (Isocitrate Dehydrogenase 1) Mutation | acute myeloid leukemia, myelodysplastic syndrome | Recruiting | Phase 2 | 2026-08-26 | NCT06717958 | |
| GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of Adult Acute Lymphoblastic Leukemia (ALL) Patients and Related Diseases Associated With a Prospective Collection of Biomaterial | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoma, lymphoproliferative syndrome, neoplasm, non-Hodgkin lymphoma | Recruiting | Not stated | 2026-08-05 | NCT02872987 | |
| (Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic Mastocytosis | Hemic and Lymphatic Diseases, Mast Cell Activation Disorders, Mastocytosis, Systemic, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, connective tissue neoplasm, hematologic disorder, immune system disorder, indolent systemic mastocytosis, mastocytosis, neoplasm, superficial spreading melanoma, type III hypersensitivity disease | Active, not recruiting | Phase 2 | 2026-05-22 | NCT05186753 | |
| TRICuspid Intervention in Heart Failure Trial | Heart Failure Attributable to Severe Tricuspid Regurgitation | Active, not recruiting | Not applicable | 2026-05-22 | NCT04634266 | |
| Randomized Trial of TAVI vs. SAVR in Patients With Severe Aortic Valve Stenosis at Low to Intermediate Risk of Mortality | Ventricular Outflow Obstruction, aortic valve disorder, aortic valve stenosis, cardiovascular disorder, heart disorder, heart valve disorder | Active, not recruiting | Not applicable | 2026-05-15 | NCT03112980 | |
| Safety and Efficacy Evaluation of the iNstroke 4F Thromboaspiration Catheter in Patients With Acute Ischaemic Stroke Due to Primary Distal Medium Vessel Occlusions (DMVO) | Acute Ischemic Stroke, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic disease, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Not applicable | 2026-01-23 | NCT07357285 | |
| Bemarituzumab in FGFR2b+ Patients With Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction, Who Failed at Least One Prior Line of Palliative Chemotherapy | Metastatic Gastro-esophageal Adenocarcinoma | Active, not recruiting | Phase 2 | 2026-01-07 | NCT06680622 | |
| Fosfomycin I.v. for Treatment of Severely Infected Patients | Bacterial Infections and Mycoses, Bone Diseases, Infectious, Brain Abscess, Cardiovascular Infections, Central Nervous System Bacterial Infections, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Infections, Inflammation, Intraabdominal Infections, Male Urogenital Diseases, Neuroinflammatory Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Skin and Connective Tissue Diseases, Soft Tissue Infections, Suppuration, Systemic Inflammatory Response Syndrome, Urogenital Diseases, abscess, bacterial endocarditis, bacterial infectious disease, bacterial infectious disease with sepsis, bacterial meningitis, bacterial pneumonia, bone disorder, brain disorder, cardiovascular disorder, central nervous system disorder, central nervous system infectious disorder, encephalitis, endocarditis, gram-negative bacterial infections, gram-positive bacterial infections, heart disorder, lung disorder, meningitis, musculoskeletal system disorder, nervous system disorder, osteomyelitis, pneumonia, respiratory system disorder, respiratory tract infectious disorder, skin disease caused by bacterial infection, skin disorder, skin disorder caused by infection, urinary system disorder, urinary tract infection | Recruiting | Not stated | 2024-10-01 | NCT02979951 |